Patriot Financial Group Insurance Agency’s Adaptive Biotechnologies ADPT Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-423	Closed	-$3K	–	433
2022 Q2	$3K	Sell	423 -36	-8%	-$317	﹤0.01%	1596
2022 Q1	$6K	Buy	459 +259	+130%	+$4.07K	﹤0.01%	1528
2021 Q4	$6K	Hold	200	–	–	﹤0.01%	1637
2021 Q3	$7K	Hold	200	–	–	﹤0.01%	1582
2021 Q2	$8K	Hold	200	–	–	﹤0.01%	1499
2021 Q1	$8K	Buy	+200	New	+$10.8K	﹤0.01%	1412

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Patriot Financial Group Insurance Agency's ADPT Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Adaptive Biotechnologies (ADPT) in Q3 2022, closing a stake of 423 shares — an estimated $3K sold.

Patriot Financial Group Insurance Agency first reported a position in ADPT in Q1 2021 and held it in 6 quarters. The position peaked at $8K in Q2 2021. 226 funds tracked by Wall St. Rank hold ADPT as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining Adaptive Biotechnologies position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 423 Adaptive Biotechnologies shares in Q3 2022, an estimated $3K.
Patriot Financial Group Insurance Agency first reported a position in Adaptive Biotechnologies in Q1 2021 and held it in 6 quarters.
Patriot Financial Group Insurance Agency's Adaptive Biotechnologies position peaked at $8K in Q2 2021.
226 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.